A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients
Clinical trial NCT01951053 · COMPLETED
Trial details
- NCT number
- NCT01951053
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-05-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.